|Issuer:||CARA THERAPEUTICS, INC. (CARA)|
|Original Submission Date:|
C/O CARA THERAPEUTICS, INC., 107 ELM ST.
4 STAMFORD PLAZA STAMFORD, CT 06902
|Title of Security||Transaction Date||2a. Deemed Execution Date||Transaction Code||Shares||Acquired or Disposed||Price per share||5. Amount of Securities Beneficially Owned Following Reported Transaction||6. Ownership Form Direct or Indirect||Nature of Indirect Ownership|
|Title of Derivative Security||Conversion or Exercise Price of Derivative Security||Transaction Date||Deemed Execution Date||Transaction Code||Number of Derivative Securities Acquired (A) or Disposed of (D)||Date Exercisable||Expiration Date||Title and Amount of Securities Underlying Derivative Security||Price of Derivative Security||Number of derivative Securities Beneficially Owned Following Reported Transaction(s)||Ownership Form: Direct (D) or Indirect (I)||Nature of Indirect Beneficial Ownership|
|EMPLOYEE STOCK OPTION (RIGHT TO BUY)||16.36||2020-02-24||deemed execution date||A||30,000 (a)||2030-02-24||common stock 30,000||$16.36||30,000||direct|
|f1||the shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on march 24, 2020, in each case subject to the reporting person's continued service (as that term is defined in the issuer's 2014 equity incentive plan) as of each such date.|